Kenneth W. Harder
- Molecular Biology top 5%
- Immunology top 2%
- Oncology top 5%
- Physiology top 10%
- Genetics top 5%
- Co-authors
- Margaret L. HibbsFrank R. JirikDavid M. TarlintonYuekang XuNicholas D. HuntingtonNicole KountouriIan Clark‐LewisCathy Quilici
- Topics
- Immune Cell Function and Interaction (18 papers)T-cell and B-cell Immunology (12 papers)Protein Tyrosine Phosphatases (11 papers)
- Partner nations
- CanadaAustraliaUnited States
In The Last Decade
Kenneth W. Harder
49 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 104
- Molecular Biology 1.5k
- Immunology 1.4k
- Oncology 504
- Physiology 241
- Genetics 229
Countries citing papers authored by Kenneth W. Harder
This map shows the geographic impact of Kenneth W. Harder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth W. Harder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth W. Harder more than expected).
Fields of papers citing papers by Kenneth W. Harder
This network shows the impact of papers produced by Kenneth W. Harder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth W. Harder. The network helps show where Kenneth W. Harder may publish in the future.
Co-authorship network of co-authors of Kenneth W. Harder
This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth W. Harder. A scholar is included among the top collaborators of Kenneth W. Harder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth W. Harder. Kenneth W. Harder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 5 | |
| 3 | 1 | |
| 4 | 30 | |
| 5 | 42 | |
| 6 | 63 | |
| 7 | 276 | |
| 8 | 27 | |
| 9 | 33 | |
| 10 | 38 | |
| 11 | 69 | |
| 12 | 149 | |
| 13 | 117 | |
| 14 | 24 | |
| 15 | 28 | |
| 16 | 51 | |
| 17 | Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A. | 82 |
| 18 | 17 | |
| 19 | 10 | |
| 20 | 35 |
About Kenneth W. Harder
Kenneth W. Harder is a scholar working on Immunology, Immunology and Allergy and Oncology, having authored 49 papers that have together received 2.9k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (18 papers), T-cell and B-cell Immunology (12 papers) and Protein Tyrosine Phosphatases (11 papers). The work is most often cited by research in Immunology (1.4k citations), Immunology and Allergy (208 citations) and Genetics (229 citations). Kenneth W. Harder has collaborated with scholars based in Canada, Australia and United States. Frequent co-authors include Margaret L. Hibbs, Frank R. Jirik, David M. Tarlinton, Yuekang Xu, Nicholas D. Huntington, Nicole Kountouri, Ian Clark‐Lewis, Cathy Quilici, Ruedi Aebersold and Ashley R. Dunn. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.